Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation

Bibliographic Details
Title: Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation
Authors: Silva, Michael Ruberson Ribeiro da, Santos, Jéssica Barreto Ribeiro dos, Almeida, Alessandra Maciel, Alvares-Teodoro, Juliana, Kakehasi, Adriana Maria, Acurcio, Francisco de Assis
Source: Advances in Rheumatology. January 2019 59
Publisher Information: Sociedade Brasileira de Reumatologia, 2019.
Publication Year: 2019
Subject Terms: Psoriatic arthritis, Antirheumatic agents, Health policy, Pharmaceutical services
More Details: Background: Pharmaceutical Assistance (PA) is a dynamic and multidisciplinary process that aims to supply health systems, programs or services with quality medicines, enabling access and health care, in an efficient and timely manner. The objective of the study was to evaluate the profile of administrative processes for the treatment of PsA, identify the time elapsed in the flow of processes and its associated factors. Methods: A cross-sectional study of medication requests for the treatment of PsA was carried out between November 2014 and December 2016. Linear regression was used to verify the factors associated with time to delivery. Results: A total of 218 cases containing 250 drugs were analyzed. The median time between the medical appointment and the first dispensation was 66 days (interquartile range, 44-90). The State proceedings, which includes requesting the drug until the authorization of treatment, was the stage that most contributed to the total time spent. The factors associated with the longer time to delivery of medications were prescriptions coming from clinics and specialty centers, from dermatologists, non-authorized processes and non-persistent patients in the treatment in 12 months. Conclusion: The median time to receive medicines for the PsA treatment in Belo Horizonte health region after a medical prescription was higher than 2 months. The time between the solicitation of the medicines and the authorization of the treatment in the SUS (State administrative procedure) was the main component of the total time spent.
Document Type: article
File Description: text/html
Language: English
ISSN: 2523-3106
DOI: 10.1186/s42358-019-0091-7
Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2523-31062019000100234
Rights: info:eu-repo/semantics/openAccess
Accession Number: edssci.S2523.31062019000100234
Database: SciELO
More Details
ISSN:25233106
DOI:10.1186/s42358-019-0091-7
Published in:Advances in Rheumatology
Language:English